Fig. 3

Targeting EZH2 modification for cancer therapy. Overview of the moleculars (black) and pharmacologic small-molecular compounds (red) regulations of EZH2. A lot of small-molecular compounds have been developed to target the major enzymes, which can regulate EZH2 HMT activity and EZH2 ubiquitination modifications. Arrows indicate positive effects, and perpendicular bars indicate negative effects